The Beauty Health Company
$0.88
▼
-2.4%
2026-04-21 09:26:00
www.beautyhealth.com
NCM: SKIN
Explore The Beauty Health Company stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$112.86 M
Current Price
$0.88
52W High / Low
$2.69 / $0.76
Stock P/E
—
Book Value
$0.48
Dividend Yield
—
ROCE
-6.64%
ROE
-16.87%
Face Value
—
EPS
$-0.16
Exp Qtr EPS
—
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
613
Beta
1.24
Debt / Equity
620.34
Current Ratio
1.66
Quick Ratio
1.4
Forward P/E
6.91
Price / Sales
0.38
Enterprise Value
$262.8 M
EV / EBITDA
57.81
EV / Revenue
0.87
Rating
None
Target Price
$1.69
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Church & Dwight Co., Inc. | $92.59 | 30.73 | $22 B | 1.27% | 14.53% | 17.62% | $106.12 / $81.33 | $16.92 |
| 2. | The Clorox Company | $98.16 | 16.06 | $11.94 B | 4.74% | 32.32% | 9.87% | $143.96 / $96.66 | $-1.03 |
| 3. | Spectrum Brands Holdings, Inc. | $85.41 | 18.91 | $1.98 B | 2.2% | 5.23% | 5.35% | $85.45 / $49.99 | $81.52 |
| 4. | The Procter & Gamble Company | $142.68 | 21.14 | $332.05 B | 3.01% | 22.93% | 31.56% | $171.65 / $137.62 | $22.49 |
| 5. | Nu Skin Enterprises, Inc. | $7.82 | 2.34 | $375.53 M | 3.07% | 7.96% | 22% | $14.62 / $5.32 | $16.71 |
| 6. | Newell Brands Inc. | $4.37 | — | $1.86 B | 6.41% | 5.75% | -11.09% | $6.63 / $3.07 | $5.7 |
| 7. | Magnera Corporation | $11.08 | — | $404.95 M | — | 1.56% | -12.41% | $15.64 / $7.82 | $28.91 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 82.37 M | 70.66 M | 78.19 M | 69.58 M | 83.5 M |
| Operating Profit | 0.16 M | -6.24 M | -2.7 M | -12.02 M | -7.16 M |
| Net Profit | -8.1 M | -11.03 M | 19.71 M | -10.1 M | -10.33 M |
| EPS in Rs | -0.06 | -0.09 | 0.15 | -0.08 | -0.08 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 300.79 M | 334.29 M | 397.99 M | 365.88 M |
| Operating Profit | -20.8 M | -67.77 M | -130.92 M | -25.84 M |
| Net Profit | -9.52 M | -29.1 M | -100.12 M | 44.22 M |
| EPS in Rs | -0.07 | -0.23 | -0.78 | 0.35 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 499.8 M | 685.68 M | 929.11 M | 1 B |
| Total Liabilities | 438.75 M | 633.88 M | 869.72 M | 836.03 M |
| Equity | 61.06 M | 51.8 M | 59.39 M | 167.05 M |
| Current Assets | 309.52 M | 477.12 M | 698.25 M | 783.27 M |
| Current Liabilities | 186.28 M | 68.15 M | 115.01 M | 71.71 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 37.48 M | 16.13 M | 21.75 M | -106.6 M |
| Investing CF | -5.16 M | -6.79 M | -31.51 M | -18.87 M |
| Financing CF | -174.93 M | -158.34 M | -37.45 M | -205.24 M |
| Free CF | 32.32 M | 9.34 M | 8.7 M | -123.99 M |
| Capex | -5.16 M | -6.79 M | -13.05 M | -17.39 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -10.02% | -16% | 8.78% | — |
| Earnings Growth % | 67.29% | 70.94% | -326.38% | — |
| Profit Margin % | -3.16% | -8.7% | -25.16% | 12.09% |
| Operating Margin % | -6.92% | -20.27% | -32.89% | -7.06% |
| Gross Margin % | 65.28% | 54.53% | 38.97% | 68% |
| EBITDA Margin % | 12.88% | 4.35% | -13.46% | 22.3% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.